These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 1785421)
1. [Clinical response of chemotherapeutic agents with different activities on chronic complicated pyelonephritis with renal stone. A proposed index of local antimicrobial activity]. Suzuki K; Horiba M; Nagata Y; Naide Y Hinyokika Kiyo; 1991 Sep; 37(9):963-8. PubMed ID: 1785421 [TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activity of fosfomycin in chronic kidney infections]. Schena FP; Selvaggi FP; Montagna MT; Salvatore C Minerva Med; 1978 Dec; 69(59):4097-104. PubMed ID: 105327 [TBL] [Abstract][Full Text] [Related]
3. [Effect of chemotherapy on kidney function in pyelonephritis due to calculi with kidney insufficiency]. Mushold R; Dutz H; Precht K; Buder HW; Schimmelpfennig R Z Urol Nephrol; 1978 Sep; 71(9):593-9. PubMed ID: 716643 [TBL] [Abstract][Full Text] [Related]
4. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi. Grasso M; Conlin M; Bagley D J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874 [TBL] [Abstract][Full Text] [Related]
5. [Comparative evaluation of the blood coagulation in non-calculous and calculous pyelonephritis]. Bezborod'ko BN; Sakhno LP Vrach Delo; 1971 Aug; 8():9-12. PubMed ID: 5143079 [No Abstract] [Full Text] [Related]
6. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates. Yu WL; Lin CW; Wang DY J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154 [TBL] [Abstract][Full Text] [Related]
7. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance. Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144 [TBL] [Abstract][Full Text] [Related]
8. [A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections]. Suzuki K; Takanashi K; Naide Y; Fujita T; Ogawa T; Hirabayashi S; Tamai H; Yanaoka M; Ishiguro K; Asano H Hinyokika Kiyo; 1986 Sep; 32(9):1387-408. PubMed ID: 3101448 [TBL] [Abstract][Full Text] [Related]
9. Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens. Haraoka M; Matsumoto T; Mizunoe Y; Ogata N; Takahashi K; Kubo S; Tanaka M; Kumazawa J Ren Fail; 1993; 15(5):567-71. PubMed ID: 8290701 [TBL] [Abstract][Full Text] [Related]
10. [Renal infections and implicated urinary stone formation]. Hirano S; Ohkawa M; Nakajima T; Orito M; Sugata T; Hisazumi H Hinyokika Kiyo; 1985 Aug; 31(8):1387-91. PubMed ID: 3909792 [TBL] [Abstract][Full Text] [Related]
11. Preventive effect of dapsone on renal scarring following mannose-sensitive piliated bacterial infection. Mochida O; Matsumoto T; Mizunoe Y; Sakumoto M; Abe J; Kumazawa J Chemotherapy; 1998; 44(1):36-41. PubMed ID: 9444407 [TBL] [Abstract][Full Text] [Related]
12. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Hiyama L; Tang A; Miller LG Am J Kidney Dis; 2006 Jan; 47(1):e9-13. PubMed ID: 16377378 [TBL] [Abstract][Full Text] [Related]
13. [Results of treatment of chronic exacerbated pyelonephritis with unroantiseptics under clinical conditions]. Todorova L; Belovezhdov N; Neshev KH; Peneva S Vutr Boles; 1976; 15(4):67-73. PubMed ID: 1007240 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial agents in the management of urinary tract infection: an experimental evaluation. Lecamwasam JP; Miller TE J Lab Clin Med; 1989 Nov; 114(5):510-9. PubMed ID: 2681480 [TBL] [Abstract][Full Text] [Related]
15. [Pyelonephritis in pregnancy]. Kremling H Med Klin; 1981 Jul; 76(14):392-4. PubMed ID: 7019653 [No Abstract] [Full Text] [Related]
16. Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure. Lefort A; Righi S; Jauréguy F; Bégué T; Robineau M; Bouchaud O; Lortholary O J Infect; 2005 Aug; 51(2):E45-7. PubMed ID: 16038749 [TBL] [Abstract][Full Text] [Related]
17. [Value of antibacterial therapy in chronic obstructive urinary tract infections]. Hofmann W; Rumohr T; Patsch R Z Urol Nephrol; 1987 Oct; 80(10):595-600. PubMed ID: 3324549 [TBL] [Abstract][Full Text] [Related]
18. Successful medical management of recurrent emphysematous pyelonephritis. Ramanathan V; Nguyen PT; Van Nguyen P; Khan A; Musher D Urology; 2006 Mar; 67(3):623.e11-3. PubMed ID: 16504262 [TBL] [Abstract][Full Text] [Related]
19. First generation cephalosporins as therapy for uncomplicated pyelonephritis in children. A retrospective analysis. Somech R; Belson A; Assia A; Jurgenson U; Spirer Z; Reif S J Med; 2000; 31(3-4):195-203. PubMed ID: 11280451 [TBL] [Abstract][Full Text] [Related]
20. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage]. Golovanov SA; Drozhzheva VV Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]